▶ 調査レポート

心臓補助装置の世界市場:製品別、地域別分析

• 英文タイトル:Global Cardiac Assist Devices Market - Segmented by Product and Geography - Growth, Trends, and Forecast (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。心臓補助装置の世界市場:製品別、地域別分析 / Global Cardiac Assist Devices Market - Segmented by Product and Geography - Growth, Trends, and Forecast (2018 - 2023) / B-MOR-05116資料のイメージです。• レポートコード:B-MOR-05116
• 出版社/出版日:Mordor Intelligence / 2018年4月
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:Healthcare
• 販売価格(消費税別)
  Single User(1名様用)¥450,500 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥477,000 (USD4,500)▷ お問い合わせ
  Corporate User¥927,500 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、心臓補助装置の世界市場について調べ、心臓補助装置の世界規模、市場動向、市場環境、製品別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・心臓補助装置の世界市場インサイト
・心臓補助装置の世界市場環境
・心臓補助装置の世界市場動向
・心臓補助装置の世界市場規模
・心臓補助装置の世界市場規模:製品別
・心臓補助装置の世界市場:地域別市場規模・分析
・心臓補助装置の北米市場規模・予測
・心臓補助装置のアメリカ市場規模・予測
・心臓補助装置のヨーロッパ市場規模・予測
・心臓補助装置のアジア市場規模・予測
・心臓補助装置の日本市場規模・予測
・心臓補助装置の中国市場規模・予測
・心臓補助装置のインド市場規模・予測
・心臓補助装置の韓国市場規模・予測
・関連企業情報・競争状況

The global cardiac assist devices market is expected to witness a CAGR of 8.5% during the forecast period (2018-2023). In the segmentation based on products type, ventricular assist devices are expected to dominate the global market.

Increasing Advancements in Technology

The continuously rapid advancements in the assist devices technologies and the novel applications of the existing treatments have led to an increase in the cardiac assist devices. In March 2015, FDA approved the Impella 2.5 System, which helps the patients in maintaining a stable heart function and circulation during certain high-risk percutaneous coronary intervention (HRPCI) procedures. Engineers are also exploring many other innovative solutions which helps in the implant success and is driving the cardiac assist devices market. Hence, the market is dependent upon the large number of innovations for growth.
Other factors responsible for the market growth are lack of donor’s hearts for transplantation, aging population, and increasing heart diseases, these factors are leading to the increase in cardiac assist devices implantations in patients with severe heart complications.

High Costs of the Instruments

The cardiac assist devices are highly expensive. The high costs of the devices and the low per capita income in the developing and underdeveloped countries is likely to impede the market of cardiac assist devices in low-income countries. The healthcare facility in these countries is still not well developed and advanced technologies are not affordable for the population owing to the high cost, thereby, restraining the growth of the market.
Other factors such as availability of alternative treatments, like pacemakers, and the risk associated with device implantation also hindering the market growth.

North America is leading the Market

North America is the leading market because of the high rate of heart failure cases that are being diagnosed every year. Europe holds the second largest market is owing to the increasing geriatric population. The APAC regions have a large number of underserved patients suffering from cardiac diseases, hence, they represent an attractive future market for cardiac assist devices.

Key Developments in the Market

• August 2017: Abbott introduced HeartMate 3 Left Ventricular Assist System, the latest milestone in therapy for advanced heart failure patients.

Major Players: ABIOMED INC., BERLIN HEART GMBH, BIOHEART INC., BIVACOR PTY LTD, BRAILE BIOMEDICA LTD, CALON CARDIO-TECHNOLOGY LTD, CARDIAC ASSIST INC., CARDIOBRIDGE GMBH, CIRCULITE INC., AND CARDIOKINETIX INC., amongst others.

Reasons to Purchase this Report

• Current and future cardiac assist devices market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• Analysis on the segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Advancements in Technology
6.1.2 Aging Population
6.1.3 Increasing Heart Disease Prevalence
6.1.4 Shortage of Heart Donors in Transplantation
6.2 Market restraints
6.2.1 Expensive Instrument and Maintenance
6.2.2 Availability of Alternative Treatments like Pacemakers
6.2.3 Risk Associated with Device Implantation
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 -By Product
7.1.1 Intra-Aortic Balloon Pumps
7.1.2 Total Artificial Heart
7.1.3 Ventricular Assist Devices
7.1.3.1 Left Ventricular Assist Device
7.1.3.2 Right Ventricular Assist Device
7.1.3.3 Bi-Ventricular Assist Device
7.1.3.4 External Ventricular Assist Device
7.2 -By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia & New Zealand
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South africa
7.2.4.3 Rest of the Middle East & Africa
7.2.5 South america
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key players
9.1 Abiomed Inc.
9.2 Abbott
9.3 Berlin Heart Gmbh
9.4 Bioheart, Inc.
9.5 Bivacor Pty Ltd
9.6 Braile Biomedica Ltd
9.7 Calon Cardio-Technology Ltd
9.8 Cardiac Assist, Inc.
9.9 Cardiobridge GmbH
9.10 Circulite, Inc.
9.11 Cardiokinetix, Inc.
9.12 List not exhaustive
10. Future of the market